DT
Defence Therapeutics Inc.
DTCFF · OTC
$0.34 +0.78% (+$0.00)
1M -4.45%
Market Cap $36.2M
P/E Ratio -
Div. Yield -
ROE 1,379.11%
Bulios Fair Price
$0.31
9.9% downside
Trenutna cena
$0.34
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica DTCFF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
17 /100
Expensive P/B 6.67x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 52.21%
ROE 1,379.11%
ROA 65.40%
Debt
69 /100
Low Debt/Equity 0.29x
Current ratio 3.37x
Int. coverage -19.19x
Stability
18 /100
Unstable Beta 1.35x
EPS volatility 88.26%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o DTCFF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Amie Phinney
Employees
1,300
Headquarters
Montreal